DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,917,247 | +6.2% | 31,688 | +6.1% | 0.32% | +1.6% |
Q1 2024 | $7,456,140 | +16.3% | 29,858 | +7.7% | 0.32% | +10.1% |
Q4 2023 | $6,411,125 | -21.3% | 27,713 | -15.6% | 0.29% | -24.4% |
Q3 2023 | $8,146,364 | +111326.1% | 32,835 | +7.8% | 0.38% | +4.4% |
Q2 2023 | $7,311 | -12.9% | 30,464 | -8.5% | 0.36% | -16.1% |
Q1 2023 | $8,391 | -16.9% | 33,294 | -12.5% | 0.44% | -10.1% |
Q4 2022 | $10,101 | -99.9% | 38,056 | -2.2% | 0.48% | -17.4% |
Q3 2022 | $10,047,000 | -1.7% | 38,900 | -3.5% | 0.59% | -1.2% |
Q2 2022 | $10,217,000 | -11.3% | 40,300 | +2.7% | 0.59% | -5.9% |
Q1 2022 | $11,513,000 | -18.9% | 39,248 | -9.0% | 0.63% | -28.2% |
Q4 2021 | $14,190,000 | +10.2% | 43,130 | +1.9% | 0.88% | -3.9% |
Q3 2021 | $12,880,000 | +11.5% | 42,306 | -1.7% | 0.91% | +66.8% |
Q2 2021 | $11,550,000 | +7.9% | 43,041 | -9.5% | 0.55% | -30.7% |
Q1 2021 | $10,703,000 | +7.0% | 47,551 | +5.6% | 0.79% | -20.0% |
Q4 2020 | $10,002,000 | -23.0% | 45,024 | -25.4% | 0.99% | -30.7% |
Q3 2020 | $12,996,000 | +12.5% | 60,354 | -7.6% | 1.43% | +30.3% |
Q2 2020 | $11,549,000 | +63.1% | 65,314 | +27.7% | 1.10% | -18.0% |
Q1 2020 | $7,082,000 | -33.3% | 51,165 | -26.1% | 1.34% | +49.9% |
Q4 2019 | $10,624,000 | +2.8% | 69,195 | -3.3% | 0.89% | +6.4% |
Q3 2019 | $10,332,000 | +5.6% | 71,535 | +4.5% | 0.84% | +1.9% |
Q2 2019 | $9,788,000 | -9.5% | 68,485 | -16.4% | 0.82% | -10.1% |
Q1 2019 | $10,818,000 | +31.4% | 81,941 | +2.6% | 0.91% | +19.0% |
Q4 2018 | $8,235,000 | -6.1% | 79,861 | -1.0% | 0.77% | +7.7% |
Q3 2018 | $8,768,000 | +19.5% | 80,691 | +8.5% | 0.71% | +9.4% |
Q2 2018 | $7,338,000 | +12.0% | 74,366 | +11.1% | 0.65% | +4.7% |
Q1 2018 | $6,553,000 | +13.8% | 66,926 | +7.9% | 0.62% | +13.7% |
Q4 2017 | $5,758,000 | +1.2% | 62,037 | -6.5% | 0.55% | -2.0% |
Q3 2017 | $5,691,000 | +5.2% | 66,342 | +3.5% | 0.56% | +1.1% |
Q2 2017 | $5,408,000 | +12.8% | 64,082 | +14.3% | 0.55% | +8.0% |
Q1 2017 | $4,794,000 | +6.8% | 56,047 | -2.8% | 0.51% | +2.2% |
Q4 2016 | $4,490,000 | +34.9% | 57,688 | +35.8% | 0.50% | +28.5% |
Q3 2016 | $3,329,000 | -24.0% | 42,471 | -2.1% | 0.39% | -37.8% |
Q2 2016 | $4,379,000 | +9.3% | 43,360 | +2.7% | 0.63% | -30.9% |
Q1 2016 | $4,005,000 | +6.6% | 42,221 | +4.3% | 0.91% | +6.6% |
Q4 2015 | $3,758,000 | +14.7% | 40,463 | +5.3% | 0.85% | +6.1% |
Q3 2015 | $3,275,000 | -10.2% | 38,437 | -9.8% | 0.80% | -6.4% |
Q2 2015 | $3,647,000 | +6.2% | 42,608 | +5.4% | 0.86% | +3.4% |
Q1 2015 | $3,433,000 | +5.6% | 40,435 | +6.6% | 0.83% | +5.9% |
Q4 2014 | $3,252,000 | +3.1% | 37,940 | -8.6% | 0.78% | +5.5% |
Q3 2014 | $3,153,000 | -29.3% | 41,503 | -26.8% | 0.74% | -19.2% |
Q2 2014 | $4,462,000 | +2.2% | 56,675 | -2.6% | 0.92% | -2.7% |
Q1 2014 | $4,365,000 | -4.2% | 58,205 | -1.4% | 0.94% | -2.0% |
Q4 2013 | $4,557,000 | +9.3% | 59,025 | -1.8% | 0.96% | +2.1% |
Q3 2013 | $4,168,000 | +5.0% | 60,130 | -3.9% | 0.94% | +0.7% |
Q2 2013 | $3,968,000 | – | 62,574 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |